miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma

Drug resistance remains the major clinical barrier to successful treatment in epithelial ovarian carcinoma (EOC) patients, and the evidence of microRNA involvement in drug resistance has been recently emerging. Endothelin-1 (ET-1)/ET(A) receptor (ET(A)R) axis is aberrantly activated in chemoresistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Sestito, Rosanna, Cianfrocca, Roberta, Rosanò, Laura, Tocci, Piera, Semprucci, Elisa, Di Castro, Valeriana, Caprara, Valentina, Ferrandina, Gabriella, Sacconi, Andrea, Blandino, Giovanni, Bagnato, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826186/
https://www.ncbi.nlm.nih.gov/pubmed/26675258
http://dx.doi.org/10.18632/oncotarget.6546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826186/
https://www.ncbi.nlm.nih.gov/pubmed/26675258
http://dx.doi.org/10.18632/oncotarget.6546

Ejemplares similares